BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22770942)

  • 1. Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity.
    Yao X; Li G; Lü C; Xu H; Yin Z
    Int Immunopharmacol; 2012 Oct; 14(2):138-44. PubMed ID: 22770942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin promotes degradation of inducible nitric oxide synthase and suppresses its enzyme activity in RAW 264.7 cells.
    Ben P; Liu J; Lu C; Xu Y; Xin Y; Fu J; Huang H; Zhang Z; Gao Y; Luo L; Yin Z
    Int Immunopharmacol; 2011 Feb; 11(2):179-86. PubMed ID: 21094287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway.
    Zhao F; Wang L; Liu K
    J Ethnopharmacol; 2009 Apr; 122(3):457-62. PubMed ID: 19429312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages.
    Cho MK; Park JW; Jang YP; Kim YC; Kim SG
    Int Immunopharmacol; 2002 Jan; 2(1):105-16. PubMed ID: 11789661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway.
    Kou X; Qi S; Dai W; Luo L; Yin Z
    Int Immunopharmacol; 2011 Aug; 11(8):1095-102. PubMed ID: 21426947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation.
    Chen L; Kong X; Fu J; Xu Y; Fang S; Hua P; Luo L; Yin Z
    Cell Immunol; 2009; 258(1):38-43. PubMed ID: 19362296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition.
    Cho MK; Jang YP; Kim YC; Kim SG
    Int Immunopharmacol; 2004 Oct; 4(10-11):1419-29. PubMed ID: 15313439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arctigenin Protects against Lipopolysaccharide-Induced Pulmonary Oxidative Stress and Inflammation in a Mouse Model via Suppression of MAPK, HO-1, and iNOS Signaling.
    Zhang WZ; Jiang ZK; He BX; Liu XB
    Inflammation; 2015 Aug; 38(4):1406-14. PubMed ID: 25616905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.
    Huang K; Li LA; Meng YG; You YQ; Fu XY; Song L
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):507-11. PubMed ID: 24842412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6.
    Lee J; Tae N; Lee JJ; Kim T; Lee JH
    Eur J Pharmacol; 2010 Jun; 636(1-3):173-80. PubMed ID: 20353767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
    Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
    Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
    J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of inducible nitric oxide synthase expression by nyasol and broussonin A, two phenolic compounds from Anemarrhena asphodeloides, through NF-κB transcriptional regulation in vitro and in vivo.
    Jin Lee E; Chung HJ; Pyee Y; Hong JY; Joung Youn U; Seo EK; Kook Lee S
    Chem Biodivers; 2014 May; 11(5):749-59. PubMed ID: 24827684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells.
    Kim JH; Kim DH; Baek SH; Lee HJ; Kim MR; Kwon HJ; Lee CH
    Biochem Pharmacol; 2006 Apr; 71(8):1198-205. PubMed ID: 16457781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
    Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
    Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc protoporphyrin inhibition of lipopolysaccharide-, lipoteichoic acid-, and peptidoglycan-induced nitric oxide production through stimulating iNOS protein ubiquitination.
    Chow JM; Lin HY; Shen SC; Wu MS; Lin CW; Chiu WT; Lin CH; Chen YC
    Toxicol Appl Pharmacol; 2009 Jun; 237(3):357-65. PubMed ID: 19376148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation.
    Ye M; Wang Q; Zhang W; Li Z; Wang Y; Hu R
    Biochem Cell Biol; 2014 Oct; 92(5):337-48. PubMed ID: 25247252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin Ameliorates Inflammation by Regulating Accumulation and Functional Activity of MDSCs in Endotoxin Shock.
    Shi H; Dong G; Yan F; Zhang H; Li C; Ma Q; Zhang J; Ning Z; Li Z; Dai J; Ming J; Fang R; Si C; Xiong H
    Inflammation; 2018 Dec; 41(6):2090-2100. PubMed ID: 30143931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anethum graveloens flower extracts inhibited a lipopolysaccharide-induced inflammatory response by blocking iNOS expression and NF-κB activity in macrophages.
    Kim YJ; Shin Y; Lee KH; Kim TJ
    Biosci Biotechnol Biochem; 2012; 76(6):1122-7. PubMed ID: 22790933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.